Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag advanced from Revision: v3.6.4 to Revision: v3.6.5, indicating a newer version of the page metadata. This update records the latest revision in the study page's history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision stamp updated from v3.6.3 to v3.6.4, indicating a new build/version of the page content. This reflects an update to the page infrastructure rather than changes to the study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new revision of the documentation.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision tag changed from v3.6.0 to v3.6.2, indicating an update to the page content. This reflects a new release of the current study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's navigation and guidance sections were updated to include new items such as 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The Intervention / Treatment heading formatting was changed to 'Intervention/Treatment' and the revision label updated from v3.5.5 to v3.6.0, indicating a UI revision rather than data changes.SummaryDifference0.4%

- Check66 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, signaling a new version of the page without changes to study details or results.SummaryDifference0.1%

Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.